Article: Commonly Used Blood Pressure Medication Prevents Aortic Aneurysm in Mice With Marfan Syndrome, Johns Hopkins Study Shows; Research Advances Likelihood of Clinical Treatment for Inherited Vascular Condition, Affirms Promise of Genetic Research.

Byline: Johns Hopkins Medical Institutions

BALTIMORE, April 6 (AScribe Newswire) -- Scientists at Johns Hopkins have used a commonly prescribed blood pressure medicine, losartan (Cozaar), to prevent a potentially fatal weakening of arteries in mice with Marfan syndrome.

As a result, efforts are already under way with the National Heart, Lung and Blood Institute and its affiliated network of hospitals in the Pediatric Heart Health Network and The Johns Hopkins Hospital to begin a clinical trial for people with Marfan syndrome, which is expected to start in the fall.

"The results of our study in mice greatly increase the likelihood that losartan ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!